Assenagon Asset Management
EDIT icon

Assenagon Asset Management’s Editas Medicine EDIT Stock Holding History

Assenagon Asset Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-23,330
Closed -$109K – 1384
2024
Q2 		$109K Sell
23,330
-33,703
-59% -$190K ﹤0.01% 1387
2024
Q1 		$423K Buy
57,033
+18,745
+49% +$156K ﹤0.01% 1228
2023
Q4 		$388K Buy
38,288
+1,384
+4% +$12.1K ﹤0.01% 1285
2023
Q3 		$288K Buy
+36,904
New +$316K ﹤0.01% 1298
2023
Q2 		– Sell
-167,981
Closed -$1.22M – 1367
2023
Q1 		$1.22M Buy
+167,981
New +$1.49M ﹤0.01% 983
2022
Q2 		– Sell
-233,487
Closed -$4.44M – 1498
2022
Q1 		$4.44M Buy
+233,487
New +$4.34M 0.01% 554
2020
Q1 		– Sell
-26,859
Closed -$795K – 847
2019
Q4 		$795K Buy
+26,859
New +$671K 0.01% 604

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Assenagon Asset Management's EDIT Position: Q3 2024 in Review

Assenagon Asset Management sold out of Editas Medicine (EDIT) in Q3 2024, closing a stake of 23,330 shares — an estimated $109K sold.

Assenagon Asset Management first reported a position in EDIT in Q4 2019 and held it in 7 quarters. The position peaked at $4.44M in Q1 2022. 229 funds tracked by Wall St. Rank hold EDIT as of Q3 2024.

  • Assenagon Asset Management reported no remaining Editas Medicine position as of Q3 2024 after selling out during the quarter.
  • Assenagon Asset Management sold 23,330 Editas Medicine shares in Q3 2024, an estimated $109K.
  • Assenagon Asset Management first reported a position in Editas Medicine in Q4 2019 and held it in 7 quarters.
  • Assenagon Asset Management's Editas Medicine position peaked at $4.44M in Q1 2022.
  • 229 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2024.

Based on Assenagon Asset Management's 13F filing for Q3 2024, filed 23 Oct 2024.